Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Prediction Of Response To Temozolomide (Tmz)-Based Therapy By Loss Of Mgmt Expression In Patients With Advanced Neuroendocrine Tumors (Net)

Matthew H Kulke,Christine Frauenhoffer,Susanne M Hooshmand,David P Ryan,Peter C Enzinger,Jeffrey A Meyerhardt,Jeffrey W Clark,Jason L Hornick,Charles S Fuchs,Mark Redston

JOURNAL OF CLINICAL ONCOLOGY（2007）

Cited 9|Views9
No score
Abstract
4505 Background: TMZ, an oral alkylating agent, has recently been shown to be active in a subset of patients with NETs. In other tumor types, methyl-guanine methyl transferase (MGMT) expression is ...
More
Translated text
Key words
advanced neuroendocrine tumors,temozolomide,mgmt expression
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined